Arabic Arabic English English French French German German
dark

MRI can cut overdiagnoses in prostate-cancer screening by half

Most countries have not introduced nationwide prostate-cancer screening, as current methods result in overdiagnoses and excessive and unnecessary biopsies. A new study by researchers at Karolinska Institutet in Sweden, which is published in the New England Journal of Medicine, indicates that screening by magnetic resonance imaging (MRI) and targeted biopsies could potentially cut overdiagnoses by half. The results were presented today at the European Association of Urology Congress. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Reduced vs. standard CT dose for lung nodules in children, young adults with cancer

Next Post

After first dose of Pfizer vaccine, antibody, but not T-cell response, is weakened in patients receiving methotrexate

Related Posts
Total
0
Share